Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.440
+0.050 (3.60%)
At close: Dec 20, 2024, 4:00 PM
1.410
-0.030 (-2.08%)
After-hours: Dec 20, 2024, 5:00 PM EST
Outlook Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Cash & Equivalents | 32.02 | 23.39 | 17.4 | 14.48 | 12.54 | 8.02 | Upgrade
|
| Cash & Short-Term Investments | 32.02 | 23.39 | 17.4 | 14.48 | 12.54 | 8.02 | Upgrade
|
| Cash Growth | -5.00% | 34.46% | 20.17% | 15.49% | 56.40% | 366.73% | Upgrade
|
| Other Receivables | - | - | - | - | 0.8 | 1.2 | Upgrade
|
| Receivables | - | - | - | - | 0.8 | 1.2 | Upgrade
|
| Prepaid Expenses | 13.59 | 7.59 | 10.12 | 7.03 | 4.61 | 3.79 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.5 | Upgrade
|
| Total Current Assets | 45.62 | 30.98 | 27.52 | 21.51 | 17.94 | 13.5 | Upgrade
|
| Property, Plant & Equipment | 0.29 | 0.03 | 0.07 | 0.28 | 0.49 | 3.18 | Upgrade
|
| Long-Term Investments | 0.71 | 0.79 | 0.8 | 0.85 | 0.9 | - | Upgrade
|
| Long-Term Deferred Charges | 0.33 | 0.33 | 0.12 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.15 | 0.17 | 0.01 | 0.17 | 0.39 | 0.46 | Upgrade
|
| Total Assets | 47.09 | 32.3 | 28.53 | 22.81 | 19.73 | 17.13 | Upgrade
|
| Accounts Payable | 5.55 | 6.57 | 3.49 | 2.2 | 2.39 | 2.28 | Upgrade
|
| Accrued Expenses | 2.68 | 2.75 | 3.43 | 1.73 | 3.79 | 4.62 | Upgrade
|
| Current Portion of Long-Term Debt | 32.43 | 35.55 | 10.92 | 0.9 | 3.66 | 11.34 | Upgrade
|
| Current Portion of Leases | 0.03 | 0 | 0.04 | 0.07 | 0.22 | 0.19 | Upgrade
|
| Current Income Taxes Payable | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 3.97 | - | Upgrade
|
| Total Current Liabilities | 42.55 | 46.73 | 19.73 | 6.75 | 15.89 | 20.29 | Upgrade
|
| Long-Term Debt | - | - | - | 10.89 | 0.9 | 0.05 | Upgrade
|
| Long-Term Leases | 0.26 | - | 0 | 0.04 | 0.04 | 3.37 | Upgrade
|
| Other Long-Term Liabilities | 87.95 | 0.01 | 0.06 | 0.52 | 0.07 | 4.2 | Upgrade
|
| Total Liabilities | 130.77 | 46.74 | 19.79 | 18.2 | 16.91 | 27.9 | Upgrade
|
| Common Stock | 0.23 | 2.6 | 2.27 | 1.76 | 1.27 | 0.29 | Upgrade
|
| Additional Paid-In Capital | 465.07 | 450.88 | 415.4 | 345.73 | 291.27 | 238.06 | Upgrade
|
| Retained Earnings | -548.98 | -467.92 | -408.94 | -342.88 | -289.72 | -254.48 | Upgrade
|
| Total Common Equity | -83.67 | -14.44 | 8.74 | 4.61 | 2.83 | -16.13 | Upgrade
|
| Shareholders' Equity | -83.67 | -14.44 | 8.74 | 4.61 | 2.83 | -10.77 | Upgrade
|
| Total Liabilities & Equity | 47.09 | 32.3 | 28.53 | 22.81 | 19.73 | 17.13 | Upgrade
|
| Total Debt | 32.72 | 35.56 | 10.96 | 11.9 | 4.83 | 14.95 | Upgrade
|
| Net Cash (Debt) | -0.7 | -12.16 | 6.44 | 2.57 | 7.71 | -6.93 | Upgrade
|
| Net Cash Growth | - | - | 150.06% | -66.60% | - | - | Upgrade
|
| Net Cash Per Share | -0.04 | -0.97 | 0.61 | 0.34 | 2.13 | -7.62 | Upgrade
|
| Filing Date Shares Outstanding | 23.66 | 13.01 | 11.41 | 11.21 | 6.36 | 1.51 | Upgrade
|
| Total Common Shares Outstanding | 23.41 | 13.01 | 11.37 | 8.82 | 6.36 | 1.43 | Upgrade
|
| Working Capital | 3.06 | -15.75 | 7.79 | 14.76 | 2.06 | -6.79 | Upgrade
|
| Book Value Per Share | -3.57 | -1.11 | 0.77 | 0.52 | 0.44 | -11.28 | Upgrade
|
| Tangible Book Value | -83.67 | -14.44 | 8.74 | 4.61 | 2.83 | -16.13 | Upgrade
|
| Tangible Book Value Per Share | -3.57 | -1.11 | 0.77 | 0.52 | 0.44 | -11.28 | Upgrade
|
| Machinery | - | - | - | 1.07 | 1.07 | 1.07 | Upgrade
|
| Leasehold Improvements | - | - | - | - | - | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.